Home » Drug Information » Recently Approved Drugs » 1997
Medical Areas: Immunology/Infectious Diseases | Pulmonary/Respiratory Diseases
Drug Information
The following information is obtained from various newswires, published
medical journal articles, and medical conference presentations.
Company: GlaxoWellcome
Approval Status: Approved November 1997
Treatment Area: allergic rhinitis
Flonase nasal spray has been approved by the FDA for the
treatment of seasonal and perennial allergic rhintis in children
four years and older. This supplementary new dosage application
represents an extension of the product to include younger
children.
